abstract |
(57) [Summary]nIn an amount effective to produce a superadditive anti-tumor effect: (a) an anti-tumor agent in a pharmaceutically acceptable carrier and / or diluent, and (b) a pharmaceutically acceptable carrier and A composition for use in treating breast cancer in a human, comprising an aromatase inhibitor in a diluent. |